MCK Q2 2025 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q2 2025 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$93.7B+21.3% YoY

Gross Profit

$3.1B3.4% margin

Operating Income

$745M0.8% margin

Net Income

$241M0.3% margin

EPS (Diluted)

$1.86

QoQ Revenue Growth

+18.1%

Cash Flow

Operating Cash Flow

$2.1B

Free Cash Flow

$1.9B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$72.4B

Total Liabilities

$75.1B

Stockholders' Equity

-$3.0B

Cash & Equivalents

$2.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$93.7B	$77.2B	+21.3%
Gross Profit	$3.1B	$2.9B	+8.6%
Operating Income	$745M	$898M	-17.0%
Net Income	$241M	$664M	-63.7%

Revenue Segments

U.S. Pharmaceutical Segment

$85.7B92%

International Segment

$3.7B4%

Medical-Surgical Solutions Segment

$2.9B3%

Prescription Technology Solutions

$1.3B1%